SCHEMBL3909064

SCHEMBL3909064

Cc1ccc(C(C)NC(=O)c2ccc(Cl)cc2NS(=O)(=O)C2=CC=CN3SNC=C23)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNA5 P22460 1/20 0.42
CCKBR P32239 7/20 0.36
CCKAR P32238 7/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
LMNA P02545 2/20 0.33
FLT1 P17948 1/20 0.33
FLT4 P35916 1/20 0.33
KDR P35968 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HPGD P15428 1/20 0.33
HSD17B10 Q99714 1/20 0.33
POLB P06746 1/20 0.33
MAPT P10636 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
TAS1R3 Q7RTX0 1/20 0.33
TAS1R1 Q7RTX1 1/20 0.33
ACLY P53396 1/20 0.33
GPR139 Q6DWJ6 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5442656 1.00 KCNA5 (0.42) KCNA5CCKBRCCKARMEN1KMT2A
SCHEMBL3897005 0.93 PTGER4 (0.39) KCNA5CCKBRCCKARMEN1KMT2A
SCHEMBL3901296 0.93 CCKBR (0.39) KCNA5CCKBRCCKARMEN1KMT2A
SCHEMBL3909965 0.93 KCNA5 (0.42) KCNA5CCKBRCCKARMEN1KMT2A
SCHEMBL5641569 0.93 KCNA5 (0.42) KCNA5CCKBRCCKARMEN1KMT2A
SCHEMBL3909994 0.91 CCKBR (0.44) KCNA5CCKBRCCKARMEN1KMT2A
SCHEMBL3895732 0.89 KCNA5 (0.35) KCNA5CCKBRCCKARMEN1KMT2A
SCHEMBL3906717 0.88 L3MBTL1 (0.38) KCNA5CCKBRCCKARMEN1KMT2A
SCHEMBL3895742 0.88 L3MBTL1 (0.40) CCKBRCCKARMEN1KMT2ALMNA
SCHEMBL5727829 0.88 L3MBTL1 (0.40) CCKBRCCKARMEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7550492-B2 Benzo[1,2,5]thiadiazole compounds JANSSEN PHARMACEUTICA N.V. (BE) 2009-06-23 US disclosed
US-20070276016-A1 BENZO[1,2,5]THIADIAZOLE COMPOUNDS JANSSEN PHARMACEUTICA N.V. (BE) 2007-11-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070276016-A1 BENZO[1,2,5]THIADIAZOLE COMPOUNDS CCKBR, CCKAR, GIPR KCNA5 4123/4885CCKBR 1/4885CCKAR 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.